Article
Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development
1 Nov 2003
Abstract excerpt
Matrix metalloproteinases (MMPs) were initially recognised for their extracellular matrix (ECM)-degrading capability during tissue remodelling. Their importance was further highlighted by their role in metastasis. Clinical trials have since evaluated the potential of MMP inhibitors as anticancer therapeutics, but without success. These initial studies point to the complex, multifunctional capacity of MMPs in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
